| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 28,422 | 25,503 | 26,170 | 30,089 | | Cost of Revenue | 12,437 | 11,196 | 11,690 | 14,216 | | | Gross Profit | 15,985 | 14,307 | 14,480 | 15,873 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 16,578 | 14,766 | 16,037 | 16,632 | | Non Recurring |
-
| 1,500 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (593) | (1,959) | (1,557) | (758) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 38 | 30 | 36 | 35 | | Earnings Before Interest And Taxes | (556) | (1,929) | (1,521) | (723) | | Interest Expense | 35 | 36 | 38 | 43 | | Income Before Tax | (591) | (1,965) | (1,559) | (766) | | Income Tax Expense | (80) | (754) | (599) | (226) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (510) | (1,211) | (960) | (541) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (510) | (1,211) | (960) | (541) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($510) | ($1,211) | ($960) | ($541) |
|
0.26% Nasdaq 
Income Statement
